Internalized stigma among people with schizophrenia : Relationship with socio-demographic, clinical and medication-related features
Copyright © 2021 Elsevier B.V. All rights reserved..
BACKGROUND: People with schizophrenia are at high risk of suffering from stigma and internalizing it. Recently, a better understanding of the stigma process has shifted the attention from public stigma to self-stigma, which is deeply debilitating. This study aimed to assess factors associated to self-stigma by evaluating socio-demographic, clinical and treatment-related variables in a group of subjects diagnosed with schizophrenia and to identify predictors of high internalized stigma.
METHODS: Ninety-four inpatients accessing rehabilitative centers with a diagnosis of schizophrenia were included in this cross-sectional study. Measures included both patient-rated scales, assessing internalized stigma, attitude toward medications, side effects experience and subjective well-being, and clinician-rated scales, assessing schizophrenia symptoms and global clinical severity and antipsychotic-related side effects.
RESULTS: Twenty-one patients (22.3%) showed high internalized stigma while 73 (77.7%) did not. Patients experiencing more medication adverse effects and worse subjective well-being were more likely to suffer from internalized stigma according to a logistic regression analysis. Extrapyramidal, psychic and some autonomic reactions also emerged as individual predictors of self-stigma in a separate regression analysis.
CONCLUSIONS: Self-stigma and subjective medication side effects perception represent a relevant issue in patients' life and should be carefully taken into account in clinical practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:243 |
|---|---|
| Enthalten in: |
Schizophrenia research - 243(2022) vom: 22. Mai, Seite 364-371 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Barlati, Stefano [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antipsychotic Agents |
|---|
| Anmerkungen: |
Date Completed 14.06.2022 Date Revised 01.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.schres.2021.06.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327302143 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327302143 | ||
| 003 | DE-627 | ||
| 005 | 20231225200458.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.schres.2021.06.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1090.xml |
| 035 | |a (DE-627)NLM327302143 | ||
| 035 | |a (NLM)34183209 | ||
| 035 | |a (PII)S0920-9964(21)00219-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barlati, Stefano |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Internalized stigma among people with schizophrenia |b Relationship with socio-demographic, clinical and medication-related features |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2022 | ||
| 500 | |a Date Revised 01.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: People with schizophrenia are at high risk of suffering from stigma and internalizing it. Recently, a better understanding of the stigma process has shifted the attention from public stigma to self-stigma, which is deeply debilitating. This study aimed to assess factors associated to self-stigma by evaluating socio-demographic, clinical and treatment-related variables in a group of subjects diagnosed with schizophrenia and to identify predictors of high internalized stigma | ||
| 520 | |a METHODS: Ninety-four inpatients accessing rehabilitative centers with a diagnosis of schizophrenia were included in this cross-sectional study. Measures included both patient-rated scales, assessing internalized stigma, attitude toward medications, side effects experience and subjective well-being, and clinician-rated scales, assessing schizophrenia symptoms and global clinical severity and antipsychotic-related side effects | ||
| 520 | |a RESULTS: Twenty-one patients (22.3%) showed high internalized stigma while 73 (77.7%) did not. Patients experiencing more medication adverse effects and worse subjective well-being were more likely to suffer from internalized stigma according to a logistic regression analysis. Extrapyramidal, psychic and some autonomic reactions also emerged as individual predictors of self-stigma in a separate regression analysis | ||
| 520 | |a CONCLUSIONS: Self-stigma and subjective medication side effects perception represent a relevant issue in patients' life and should be carefully taken into account in clinical practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antipsychotics | |
| 650 | 4 | |a Schizophrenia | |
| 650 | 4 | |a Self-stigma | |
| 650 | 4 | |a Side effects | |
| 650 | 4 | |a Stigma | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 700 | 1 | |a Morena, Donato |e verfasserin |4 aut | |
| 700 | 1 | |a Nibbio, Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Cacciani, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Corsini, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Mosca, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Deste, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Accardo, Vivian |e verfasserin |4 aut | |
| 700 | 1 | |a Turrina, Cesare |e verfasserin |4 aut | |
| 700 | 1 | |a Valsecchi, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Vita, Antonio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Schizophrenia research |d 1989 |g 243(2022) vom: 22. Mai, Seite 364-371 |w (DE-627)NLM013111655 |x 1573-2509 |7 nnns |
| 773 | 1 | 8 | |g volume:243 |g year:2022 |g day:22 |g month:05 |g pages:364-371 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.schres.2021.06.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 243 |j 2022 |b 22 |c 05 |h 364-371 | ||